The Covid-19 booster debate begins anew

Posted by on October 14, 2021 10:00 am
Categories: Everything Else

The session follows just a few weeks after the FDA authorized Pfizer and BioNTech’s booster amid a storm of controversy over the White House’s cheerleading of the extra dose and the quality of the data underpinning it.

Leave a Reply

Your email address will not be published.